Erica McPhee
Family · Bay City, MINPI 1982155321
Payments from drug & device makers
Across 62 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$196
- Novo Nordisk$160
- AstraZeneca$107
- Dexcom, Inc.$65
- GSK$51
- Bayer$46
- plus $411 from 16 others
What the payments were for
- Food & beverage$1,036100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 12 | $196 |
| Novo Nordisk | 10 | $160 |
| AstraZeneca | 5 | $107 |
| Dexcom, Inc. | 4 | $65 |
| GSK | 4 | $51 |
| Bayer | 2 | $46 |
| Electromed, Inc. | 3 | $43 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $43 |
| AbbVie | 2 | $42 |
| Exact Sciences | 2 | $39 |
| Pfizer | 2 | $33 |
| Astellas Pharma US Inc | 2 | $30 |
| Sanofi-aventis U.S. LLC | 2 | $27 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Mylan Specialty L.p. | 1 | $20 |
| Merck | 1 | $20 |
| Lundbeck LLC | 1 | $18 |
| Bioventus LLC | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $12 |
How this compares
$1,036 in reported general payments places this provider in the 70th percentile of 3,657 family providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 41 | $47,767 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 41 | $41,301 |
| OzempicSemaglutide | 20 | $36,350 |
| EliquisApixaban | 24 | $32,923 |
| MounjaroTirzepatide | 26 | $31,945 |
| JanuviaSitagliptin Phosphate | 18 | $27,311 |
| XareltoRivaroxaban | 19 | $19,380 |
| LinzessLinaclotide | 12 | $12,633 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $12,561 |
| BrilintaTicagrelor | 11 | $4,443 |
| Atorvastatin Calcium | 216 | $2,903 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 53 | $2,448 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $2,376 |
| Losartan Potassium | 121 | $2,027 |
| Omeprazole | 130 | $1,968 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $51 | $41,30141 claims |
| Novo NordiskOzempic | $160 | $36,35020 claims |
| PfizerEliquis | $33 | $32,92324 claims |
| Lilly USA, LLCMounjaro | $196 | $31,94526 claims |
| MerckJanuvia | $20 | $27,31118 claims |
| AbbVieLinzess, Synthroid | $42 | $13,65924 claims |
| AstraZenecaBrilinta | $107 | $4,44311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,657 family providers in Michigan.
Other family in Bay City
- Tracy RobertsonBay City$47K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.